Skip to main content

Table 1 Anthropometric variables and DXA T-score. Homogeneity in anthropometric and BMD and DXA T-score in patients with established osteoporosis compared between Alendronate group and placebo control group (Data: mean ± SD)

From: Alendronate increases BMD at appendicular and axial skeletons in patients with established osteoporosis

Parameters Alendronate group Control group p value
Number of subjects 22 25 /
Age (years) 60.7 ± 6.4 59.1 ± 6.3 0.387
Years since menopause (YSM) (years) 11.2 ± 7.5 9.1 ± 5.7 0.290
Height (m) 154.3 ± 5.9 153.9 ± 5.3 0.825
Weight (kg) 54.3 ± 9.5 56.8 ± 8.5 0.358
Body mass index (BMI) 22.7 ± 3.0 23.9 ± 2.5 0.173
Spine T-score -2.21 ± 0.78 -2.20 ± 0.81 0.970
Hip T-score -1.53 ± 1.03 -1.70 ± 0.51 0.508